Development of an ALK2-Biased BMP Type I Receptor Kinase Inhibitor

  • Agustin H. Mohedas
    Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, 77 Massachusetts Ave., Cambridge, Massachusetts 02139, United States
  • Xuechao Xing
    Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women’s Hospital and Harvard Medical School, 65 Landsdowne Street, Cambridge, Massachusetts 02139, United States
  • Kelli A. Armstrong
    Department of Medicine, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St., Boston, Massachusetts 02115, United States
  • Alex N. Bullock
    Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, United Kingdom
  • Gregory D. Cuny
    Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham and Women’s Hospital and Harvard Medical School, 65 Landsdowne Street, Cambridge, Massachusetts 02139, United States
  • Paul B. Yu
    Harvard Medical School, 25 Shattuck St., Boston, Massachusetts 02115, United States

収録刊行物

  • ACS Chemical Biology

    ACS Chemical Biology 8 (6), 1291-1302, 2013-04-30

    American Chemical Society (ACS)

被引用文献 (11)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ